The company is significantly boosted its course of a novel treatment for cardiac amyloidosis, employing the compound. Preliminary patient results suggests potential improvements for those diagnosed by a severe illness. https://attruby103653.answerblogs.com/42511738/bridgebio-progresses-cardiac-amyloidosis-treatment-with-the-therapy